Pharmaceutical care for protecting an ovarian cancer patient from bleomycin pulmonary toxicity
- VernacularTitle:预防博莱霉素化疗导致卵巢癌患者肺毒性的药学监护
- Author:
Jing-Zi LI
1
;
Ying ZHOU
;
Yi-Min CUI
Author Information
1. 北京大学 第一医院 药剂科
- Keywords:
bleomycin;
pulmonary toxicity;
drug-induced pulmonary injury;
pharmaceutical care
- From:
The Chinese Journal of Clinical Pharmacology
2014;(5):456-457
- CountryChina
- Language:Chinese
-
Abstract:
Objective To provide the pharmaceutical care plan for pa-tients receiving bleomycin , which has reached toxicity dose , to prevent the drug-induced pulmonary injury.Methods Regimen was laid down for aiding doctors to prevent the potential pulmonary toxicity through tak-ing part in the therapeutic process of an ovarian cancer patient given ble-omycin which has reached toxicity dose.Results and Conclusion From three aspects of preventing , monitoring and treating , a reasonable indi-vidualized dosing regimen for patients with advanced cancer palliative care was devoleped.The adverse reactions of chemotherapy should be monitored and prevented for enhancing the quality of patients′life.
